Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
Rotavirus is one of the leading causes of severe acute gastroenteritis in children under 5 years of age, mainly affecting developing countries. Once the disease is acquired, no specific treatment is available; as such, the development of new drugs for effective antirotaviral treatment is critical. U...
| Autores principales: | , , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/6673 https://www.sciencedirect.com/science/article/pii/S0924857919301955?via%3Dihub#! https://doi.org/10.1016/j.ijantimicag.2019.07.015 |
Ejemplares similares: Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
- P26 enhances baculovirus gene delivery by modulating the mammalian antiviral response
- Baculovirus vectors induce the production of interferons in swine : their potential in the development of antiviral strategies
- Bovine interferon lambda Is a potent antiviral against SARS-CoV-2 infection in vitro
- Antiviral agents against equid alphaherpesviruses : current status and perspectives
- Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
- Antiviral efficacy of short-hairpin RNAs and artificial microRNAs targeting foot and-mouth disease virus